跳至主要内容
临床试验/NCT06637215
NCT06637215招募中不适用

Open, Parallel, Randomized Controlled, Non-inferior, Phase III Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer

First Hospital of China Medical University1 个研究点 分布在 1 个国家目标入组 352 人开始时间: 2023年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
352
试验地点
1
主要终点
Recurrence-free survival (DFS)

研究概览

简要总结

To investigate the postoperative complication incidence and long-term efficacy between ambulatory surgery for colorectal cancer and traditional laparoscopic colorectal surgery in patients with colorectal tumor who are generally in good health and have sufficient organ functions。

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients voluntarily joined this study and signed an informed consent form;
  • Age: 18-75 years old;
  • The patient should have a good general condition and no serious internal medicine comorbidities (ASA classification of the American Anesthesiology Association is Grade I~III);
  • Complete colonoscopy and colonoscopy biopsy, and the pathology is confirmed to be adenocarcinoma/high-level intraepithelial neoplasia;
  • Enhanced CT or MRI examination before surgery, indicating that the tumor diameter is ≤5.0 cm;
  • Preoperative staging: cT1-3NanyM0;
  • Strictly follow the colorectal day surgery plan, and micro-laparoscopic radical colorectal cancer treatment can be adopted;
  • There are no contraindications for abdominal wall nerve block anesthesia or non-opiate analgesic drugs;
  • Does not require conventional anticoagulant therapy or antiplatelet therapy;
  • Relatives or co-residents should be able to provide 24 hours of full escort within at least 72 hours after the operation, the place of residence is not more than a 30-minute drive from the hospital, and they can understand and follow the phased treatment plan of diet, analgesic drugs, etc. after the operation.

排除标准

  • Elderly patients with multiple basic diseases;
  • Moderate to severe anemia;
  • Severe hypoproteinemia;
  • Diabetes that is not well controlled;
  • Contraindications to laparoscopic surgery;
  • Cases of emergency surgery due to acute intestinal obstruction, perforation or bleeding;
  • Patients with distant metastases;
  • Patients who are unwilling to sign informed consent or follow-up according to the research plan;
  • People with a history of psychotropic drug abuse and unable to quit or have mental disorders;
  • Patients who live alone or in psychosocial isolation, patients who cannot understand the postoperative nursing process;
  • After the operation, the place of residence is far away from the treated hospital or patients with insufficient medical resources and inconvenient transportation;
  • According to the judgment of the researcher, there are concomitant diseases that seriously endanger the safety of the patient or affect the completion of the patient's research.

结局指标

主要结局

Recurrence-free survival (DFS)

时间窗: From enrollment to the end of treatment at 36 months

Overall survival (OS)

时间窗: From enrollment to the end of treatment at 36 months

次要结局

  • BIood system disorders(From enrollment to the end of treatment at 1 week)
  • Pain evaluation(From one hour after surgery to the end of treatment at 48 hours)
  • Cardiac disorders(From enrollment to the end of treatment at 1 week)
  • CoIonic fistuIa(From enrollment to the end of treatment at 1 week)
  • AbdominaI infection(From enrollment to the end of treatment at 1 week)
  • AnorectaI infection(From enrollment to the end of treatment at 1 week)
  • Fever(From enrollment to the end of treatment at 1 week)

研究者

发起方
First Hospital of China Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kai Li

Deputy Director of surgical Oncology

First Hospital of China Medical University

研究点 (1)

Loading locations...

相似试验